WHO Suspends HCQ Trials

The World Health Organization has temporarily suspended a clinical trial of antimalarial drugs for Covid treatment following the May 22 publication by The Lancet of a study that found no benefit from the therapy and associated risk of higher deaths from the treatment. The drugs include Hydroxychloroquine (HCQ), the antimalarial drug touted by President Donald…

Thank you for reading!

To continue reading this article you must be registered and logged into this site. If you already have an account please login now, otherwise you can click here to register for new account. Registration is FREE.

Login       Register